Moreover, lots of nicely founded adverse prognostic markers, which include U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their negative influence in individuals addressed with VO. The sole factor that remained predictive of a shorter development-cost-free survival in this cohort of clients was TP53 aberrations.112 Lastly, the choice B